Y Chen, S Li, W Hedrich, X Wu, S Li, C Qiu, K Lin… - International Journal of …, 2025 - Elsevier
Abstract Development of neutralizing monoclonal antibody (nAb) is a strategy for treatment
of infections caused by SARS-CoV-2. This study evaluated the pharmacokinetics (PK) and …